Showing results (1361-1370 of 1,409) with videos related to

Sort By:
Pageof 141
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 11, 2024
Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trialAurélien Dinh, Clara Duran, Jacques Ropers, et al.
Plos One|April 6, 2018
Trends in congenital anomalies in Europe from 1980 to 2012Joan K Morris, Anna L Springett, Ruth Greenlees, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
European Journal of Cancer (Oxford, England : 1990)|November 8, 2020
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort studyKarlijn de Joode, Daphne W Dumoulin, Jolien Tol, et al.
Nature|September 24, 2025
Industry-compatible silicon spin-qubit unit cells exceeding 99% fidelityPaul Steinacker, Nard Dumoulin Stuyck, Wee Han Lim, et al.
The Journal of Pediatrics|July 28, 2012
Recent decrease in the prevalence of congenital heart defects in EuropeBabak Khoshnood, Maria Loane, Ester Garne, et al.
Nature Genetics|July 24, 2024
Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progressionAmin Abedini, Jonathan Levinsohn, Konstantin A Klötzer, et al.
JAMA Network Open|October 15, 2021
Factors Associated With Treatment Failure in Moderately Severe Community-Acquired Pneumonia: A Secondary Analysis of a Randomized Clinical TrialAurélien Dinh, Clara Duran, Jacques Ropers, et al.
Rheumatology (Oxford, England)|July 23, 2021
Adipose tissue-derived stromal vascular fraction for treating hands of patients with systemic sclerosis: a multicentre randomized trial Autologous AD-SVF versus placebo in systemic sclerosisAurélie Daumas, Jérémy Magalon, Elisabeth Jouve, et al.
Lancet (London, England)|March 28, 2021
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trialAurélien Dinh, Jacques Ropers, Clara Duran, et al.
Pageof 141